Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis

NCT00195208 ↗

Phase 3 Completed 97 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to demonstrate pharmacodynamic comparability between the pantoprazole spheroid formulation and the marketed tablet formulation.

Timeline

Start: 2005-06
Primary completion: 2005-11
Completion: 2005-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pantoprazole	Other / unclassified	—	—

Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis

Summary

Timeline

Drugs

Indications